Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EC approves Sandoz’s biosimilar Ziextenzo for febrile neutropenia

pharmaceuticalNovember 29, 2018

Tag: Sandoz , EC , febrile neutropenia , Ziextenzo

PharmaSources Customer Service